Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients.

@article{Song2011DrugelutingBL,
  title={Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case-control study of Asian patients.},
  author={Myeong Jun Song and Chung-Hwa Park and Jin Dong Kim and Hee Yeon Kim and Si Hyun Bae and Jong Young Choi and Seung Kew Yoon and Ho Jong Chun and Byung Gil Choi and Hae Giu Lee},
  journal={European journal of gastroenterology & hepatology},
  year={2011},
  volume={23 6},
  pages={521-7}
}
OBJECTIVE Lipiodol transcatheter arterial chemoembolization (TACE) is widely used to treat hepatocellular carcinoma (HCC). Recently, a drug-eluting bead (DEB) has been developed to enhance drug delivery to the tumor and reduce its systemic availability. The purpose of this study was to compare the efficacy and safety of intra-arterial injection of DEB loaded with doxorubicin versus conventional, Lipiodol-based TACE regimens in Asian patients with HCC. METHODS The study was designed as a case… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Single-center comparison of three chemoembolization regimens for hepatocellular carcinoma.

Journal of vascular and interventional radiology : JVIR • 2013
View 2 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…